SCHEMBL4383630

SCHEMBL4383630

Cc1cc(F)c(O)c(I)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TTR P02766 2/20 0.46
SELL P14151 1/20 0.46
SELP P16109 1/20 0.46
SELE P16581 1/20 0.46
PLAU P00749 4/20 0.42
F2 P00734 2/20 0.42
F10 P00742 2/20 0.42
PLG P00747 2/20 0.42
PLAT P00750 2/20 0.42
ALB P02768 1/20 0.38
ALDH1A1 P00352 4/20 0.36
KMT2A Q03164 2/20 0.35
LMNA P02545 2/20 0.35
MEN1 O00255 1/20 0.35
HTT P42858 1/20 0.35
ACHE P22303 1/20 0.35
POLB P06746 2/20 0.34
CA2 P00918 1/20 0.34
TYR P14679 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7134885 0.84 TTR (0.61) TTRSELLSELPSELEPLAU
SCHEMBL129716 0.82 SELL (0.58) SELLSELPSELEALDH1A1KMT2A
SCHEMBL18751667 0.80 SELL (0.65) TTRSELLSELPSELEPLAU
SCHEMBL12588326 0.77 SELL (0.68) SELLSELPSELEALDH1A1KMT2A
SCHEMBL815630 0.77 ALDH1A1 (0.54) TTRSELLSELPSELEPLAU
SCHEMBL13349219 0.75 HDAC1 (0.35) SELLSELPSELEPLAUF2
SCHEMBL2209559 0.75 RAPGEF4 (0.39) SELLSELPSELEPLAUF2
SCHEMBL12217591 0.75 ALDH1A1 (0.52) SELLSELPSELEALDH1A1KMT2A
SCHEMBL11747447 0.75 TTR (0.65) TTRALBKMT2ALMNAMEN1
SCHEMBL815794 0.75 ERN1 (0.46) TTRALBKMT2ALMNAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018069532-A1 INHIBITORS OF ALPHA-AMINO-BETA-CARBOXYMUCONIC ACID SEMIALDEHYDE DECARBOXYLASE TES PHARMA S.R.L. (IT) 2018-04-19 WO disclosed
EP-1409441-B1 INDANE COMPOUNDS WITH NEGATIVE DIELECTRIC ANISOTROPY MERCK PATENT GMBH (DE) 2009-11-18 EP disclosed
US-7122228-B2 Transistros; liquid crystals display; electrooptics MERCK PATENT GMBH (DE) 2006-10-17 US disclosed
US-20040171866-A1 Transistros; liquid crystals display; electrooptics MERCK PATENTGESELLSCHAFT (DE) 2004-09-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040171866-A1 Transistros; liquid crystals display; electrooptics VCL, RIF1, IPO11 TTR 34/4885SELL 2386/4885SELP 2410/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.